GlaxoSmithKline PLC ADR Free Cash Flow Generation Index
GlaxoSmithKline PLC ADR free cash flow generation index. GlaxoSmithKline PLC ADR (GSK) has a Free Cash Flow Generation Index of 0.87x as of June 2026. Free cash flow of $2.21 Billion represents 1% of operating cash flow ($2.54 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of GlaxoSmithKline PLC ADR (1990–2025)
Free cash flow generation index of GlaxoSmithKline PLC ADR from 1990 to 2025. Historical FCF Generation Index trend for GlaxoSmithKline PLC ADR across 36 annual periods. See GlaxoSmithKline PLC ADR leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
GlaxoSmithKline PLC ADR Free Cash Flow Generation Index by Year (1990–2025)
GlaxoSmithKline PLC ADR free cash flow generation index by year from 1990 to 2025. Year-by-year Free Cash Flow Generation Index for GlaxoSmithKline PLC ADR. For the full cash flow conversion analysis, see GlaxoSmithKline PLC ADR cash flow conversion.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | $5.82 Billion | $7.14 Billion | $1.32 Billion | ▲ +49.6% |
| 2024 | 0.55x | $3.57 Billion | $6.55 Billion | $2.98 Billion | ▼ -31.3% |
| 2023 | 0.79x | $6.26 Billion | $7.89 Billion | $1.63 Billion | ▲ +14.1% |
| 2022 | 0.69x | $5.14 Billion | $7.40 Billion | $2.26 Billion | ▲ +10.1% |
| 2021 | 0.63x | $5.02 Billion | $7.95 Billion | $2.93 Billion | ▼ -14.1% |
| 2020 | 0.73x | $6.20 Billion | $8.44 Billion | $2.24 Billion | ▲ +0.6% |
| 2019 | 0.73x | $5.86 Billion | $8.02 Billion | $2.16 Billion | ▼ -7.2% |
| 2018 | 0.79x | $6.62 Billion | $8.42 Billion | $1.80 Billion | ▲ +15.4% |
| 2017 | 0.68x | $4.72 Billion | $6.92 Billion | $2.20 Billion | ▲ +6.9% |
| 2016 | 0.64x | $4.14 Billion | $6.50 Billion | $2.35 Billion | ▲ +145.4% |
| 2015 | 0.26x | $668.00 Million | $2.57 Billion | $1.90 Billion | ▼ -60.7% |
| 2014 | 0.66x | $3.42 Billion | $5.18 Billion | $1.75 Billion | ▼ -13.4% |
| 2013 | 0.76x | $5.52 Billion | $7.22 Billion | $1.70 Billion | ▲ +17.1% |
| 2012 | 0.65x | $2.85 Billion | $4.38 Billion | $1.52 Billion | ▼ -17.1% |
| 2011 | 0.79x | $4.92 Billion | $6.25 Billion | $1.33 Billion | ▲ +3.7% |
| 2010 | 0.76x | $5.16 Billion | $6.80 Billion | $1.64 Billion | ▼ -0.2% |
| 2009 | 0.76x | $5.97 Billion | $7.84 Billion | $1.87 Billion | ▲ +6.2% |
| 2008 | 0.72x | $5.24 Billion | $7.31 Billion | $2.07 Billion | ▲ +21.1% |
| 2007 | 0.59x | $3.65 Billion | $6.17 Billion | $2.14 Billion | ▲ +2.0% |
| 2006 | 0.58x | $2.37 Billion | $4.08 Billion | $1.59 Billion | ▼ -18.3% |
| 2005 | 0.71x | $4.41 Billion | $6.20 Billion | $1.18 Billion | ▼ -22.1% |
| 2004 | 0.91x | $4.51 Billion | $4.94 Billion | $255.00 Million | ▲ +16.9% |
| 2003 | 0.78x | $3.79 Billion | $4.85 Billion | $1.06 Billion | ▲ +30.4% |
| 2002 | 0.60x | $1.83 Billion | $3.06 Billion | $1.23 Billion | ▼ -20.9% |
| 2001 | 0.76x | $3.49 Billion | $4.61 Billion | $1.12 Billion | ▲ +87.3% |
| 2000 | 0.40x | $749.00 Million | $1.85 Billion | $1.10 Billion | ▲ +337.1% |
| 1999 | -0.17x | $-87.00 Million | $510.00 Million | $597.00 Million | ▼ -7.6% |
| 1998 | -0.16x | $-65.00 Million | $410.00 Million | $475.00 Million | ▼ -148.8% |
| 1997 | 0.33x | $200.00 Million | $615.00 Million | $415.00 Million | ▼ -38.4% |
| 1996 | 0.53x | $448.00 Million | $849.00 Million | $401.00 Million | ▲ +16.3% |
| 1995 | 0.45x | $568.00 Million | $1.25 Billion | $684.00 Million | ▼ -43.4% |
| 1994 | 0.80x | $1.96 Billion | $2.45 Billion | $485.59 Million | ▲ +76.6% |
| 1993 | 0.45x | $478.00 Million | $1.05 Billion | $575.00 Million | ▲ +31.9% |
| 1992 | 0.34x | $319.00 Million | $927.00 Million | $608.00 Million | ▲ +258.9% |
| 1991 | 0.10x | $63.00 Million | $657.00 Million | $594.00 Million | ▲ +555.3% |
| 1990 | 0.01x | $9.00 Million | $615.00 Million | $606.00 Million | — |